Justin Michael Oldham MD
Critical Care Medicine
Director, Interstitial Lung Disease Program
Join to View Full Profile
1500 E Medical Center DrAnn Arbor, MI 48109
Phone+1 734-936-4000
Fax+1 916-734-8080
Dr. Oldham is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of ChicagoFellowship, Pulmonary Disease and Critical Care Medicine, 2011 - 2015
University of California Davis HealthResidency, Internal Medicine, 2006 - 2009
University of Colorado School of Medicine Anschutz Medical CampusClass of 2006
Certifications & Licensure
MI State Medical License 2022 - 2028
CA State Medical License 2007 - 2023
IL State Medical License 2010 - 2017
WI State Medical License 2012 - 2017
American Board of Internal Medicine Pulmonary Disease
Publications & Presentations
PubMed
- Quantitative CT Measures of Lung Fibrosis and Outcomes in the National Lung Screening Trial.Jennifer M Wang, Swaraj Bose, Susan Murray, Wassim W Labaki, Ella A Kazerooni
Annals of the American Thoracic Society. 2025-04-10 - Proteomic Biomarkers of Survival in Non-IPF Interstitial Lung Disease.Shehabaldin Alqalyoobi, Jennifer A Smith, Manoj V Maddali, Janelle Vu Pugashetti, Chad A Newton
American Journal of Respiratory and Critical Care Medicine. 2025-04-10 - The moving target of progressive pulmonary fibrosis: insights for future clinical trials.Vincent Cottin, Valentine Mismetti, Claudia Valenzuela, Justin Oldham
The European Respiratory Journal. 2025-03-01
Press Mentions
Antifibrotic Drug Slows Decline in Lung DiseaseOctober 1st, 2019
Grant Support
- Prognostic Biomarker Development in Progressive Fibrosing Interstitial Lung DiseaseUNIVERSITY OF MICHIGAN AT ANN ARBOR2024–2028
- Prognostic Biomarker Development in Progressive Fibrosing Interstitial Lung DiseaseUNIVERSITY OF MICHIGAN AT ANN ARBOR2024–2028
- Proteomic Profiling of Idiopathic Pulmonary Fibrosis Progression TrajectoryUNIVERSITY OF MICHIGAN AT ANN ARBOR2023–2028
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
